Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Weight Management in Women of Reproductive Age

New Spirometry Standards: Key Changes for Clinical Practice

Food Allergy Prevention

Protecting Young Lungs – Paediatric Insights into RSV

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne